Any current/future new fundraising through debt or equity?

No explicit mention of any immediate or planned fundraising through debt or equity in the transcript. The company highlighted having a healthy cash balance of over INR360 crores after INR117 crores in capex over the last 16 months. Sanjay Tibrewala emphasized that the company is very cash disciplined and uses internal accruals for investments. For inorganic acquisitions, the company is prepared to use its cash reserves rather than raising new funds. The recent expansion and acquisition activities have been funded through internal accruals and prior fundraises. No direct indication of fresh equ

Any current/future capex/capital investment/strategic investment?

The company has completed significant capital expenditure (capex) of INR117 crores over the last 16 months, commissioning a new facility with Phase 1 capacity of 15,000 tons, totaling 120,000 tons fungible capacity for multiple product lines (Page 9, 5, 9). The expansion was done within cost limits and timelines, with a focus on operational readiness and quality (Page 9). No current specific new capex announced as of August 2025, but the company remains focused on both organic and inorganic growth strategies, including strategic investments in R&D, market expansion, and selective acquisitions

Future growth expectations in sales/revenue/volumes?

Fineotex expects continued strong growth driven by technical textiles, FMCG, and specialty chemicals. The company targets expanding its presence in over 70 countries with a diverse distributor network. Their recently commissioned Ambernath plant increases capacity to ~120,000 tons, supporting volume growth. Historical CAGR highlights strong growth: 28% top line and 22% revenue CAGR over 5 years. Management is optimistic about returning to peak FMCG volumes by year-end. Focus on gaining global approvals and entering new markets, especially in oil & gas specialty chemicals and water treatment. B

Future growth expectations in earnings/operating earnings/profits/EPS?

Fineotex has demonstrated strong historical growth with a 5-year PAT CAGR over 50% and revenue CAGR around 22%. Management is optimistic about volume recovery and expects to reach peak sales levels of last year by FY26-end. EBITDA margins are targeted to return to 18%-20% for the medium term, with a potential to improve further to 24%-25% in longer term as external factors become favorable. Expansion with the new Ambernath facility (120,000 tons capacity) is expected to support higher production and revenue growth. Growing order book and new businesses, especially in specialty oils, hy

Current/ Expected Orderbook/ Pending Orders?

Fineotex Chemical Limited has a healthy order book reflecting strong business performance and customer trust (Page 4). Recent quarters have seen initiation of successful trial orders for big corporates, including tanker load orders in liquids (Page 10). There is a growing pipeline of orders in water treatment and oil & gas sectors, both domestic and export markets (Page 4). The company is actively engaging with global corporate customers, including those in the Middle East and Russia for oil specialty chemicals, showing positive traction (Page 11). New plant capacity commissioned at Ambernath

IN US

Sale is live|00:00:00left today

Fineotex Chemical LtdQ2 FY25Chemicals & Petrochemicals

Fineotex Chemical Ltd Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹43P/E: 27.6Market Cap: ₹2.7K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→Fineotex expects continued strong growth driven by technical textiles, FMCG, and specialty chemicals.
→The company targets expanding its presence in over 70 countries with a diverse distributor network.
→Their recently commissioned Ambernath plant increases capacity to ~120,000 tons, supporting volume growth.
→Historical CAGR highlights strong growth: 28% top line and 22% revenue CAGR over 5 years.
→Management is optimistic about returning to peak FMCG volumes by year-end.
→Focus on gaining global approvals and entering new markets, especially in oil & gas specialty chemicals and water treatment.
→Brand building and increased marketing spend aim to sustain long-term EBITDA margins of 18-20%, eventually returning to 24-25%.
→Inorganic growth opportunities via acquisitions are under active consideration.
→Overall, Fineotex is confident in sustained volume and revenue growth fueled by innovation, capacity expansion, and market diversification.

Margin guidance

Category 3

→Fineotex has demonstrated strong historical growth with a 5-year PAT CAGR over 50% and revenue CAGR around 22%.
→Management is optimistic about volume recovery and expects to reach peak sales levels of last year by FY26-end.
→EBITDA margins are targeted to return to 18%-20% for the medium term, with a potential to improve further to 24%-25% in longer term as external factors become favorable.
→Expansion with the new Ambernath facility (120,000 tons capacity) is expected to support higher production and revenue growth.
→Growing order book and new businesses, especially in specialty oils, hygiene/FMCG, and oil & gas sectors, are likely to contribute to better profitability.
→Inorganic growth opportunities are being explored actively, which could further boost earnings.
→Continued marketing investments for brand building are anticipated to stabilize, implying improved EBITDA margins ahead.
→Overall, management is committed to delivering sustainable long-term value and expects improving earnings and profitability trends.

3 more insights locked — sign up free to unlock

Fundraise plans

→No explicit mention of any immediate or planned fundraising through debt or equity in the transcript.
→The company highlighted having a healthy cash balance of over INR360 crores after INR117 crores in capex over the last 16 months.
→Sanjay Tibrewala emphasized that the company is very cash disciplined and uses internal accruals for investments.
→For inorganic acquisitions, the company is prepared to use its cash reserves rather than raising new funds.
→The recent expansion and acquisition activities have been funded through internal accruals and prior fundraises.
→No direct indication of fresh equity or debt issuance during the current financial year was provided.
→If any inorganic deal happens, it may be funded through available cash or borrowing but no formal plan announced yet.

Order book

Yes

→Fineotex Chemical Limited has a healthy order book reflecting strong business performance and customer trust (Page 4).
→Recent quarters have seen initiation of successful trial orders for big corporates, including tanker load orders in liquids (Page 10).
→There is a growing pipeline of orders in water treatment and oil & gas sectors, both domestic and export markets (Page 4).
→The company is actively engaging with global corporate customers, including those in the Middle East and Russia for oil specialty chemicals, showing positive traction (Page 11).
→New plant capacity commissioned at Ambernath (15,000 tons capacity) supports scaling up production and order fulfillment (Page 5).
→Despite some seasonal delays (e.g., AquaStrike mosquito product revenue expected in the near future), overall order flow remains strong and growing (Page 5).
→The company expects positive updates on inorganic growth and order additions in the current financial year (Page 11).

Capex plans

Yes

→The company has completed significant capital expenditure (capex) of INR117 crores over the last 16 months, commissioning a new facility with Phase 1 capacity of 15,000 tons, totaling 120,000 tons fungible capacity for multiple product lines (Page 9, 5, 9).
→The expansion was done within cost limits and timelines, with a focus on operational readiness and quality (Page 9).
→No current specific new capex announced as of August 2025, but the company remains focused on both organic and inorganic growth strategies, including strategic investments in R&D, market expansion, and selective acquisitions aligned with its long-term vision (Page 4).
→They maintain a strong cash balance of over INR360 crores post capex, available for future inorganic opportunities (Page 11).
→The company continues to explore and advance acquisition discussions under NDA, signaling potential strategic investments or acquisitions in the near future (Pages 14, 11).

How does Fineotex Chemical Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Fineotex Chemical Ltd

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Fineotex Chemical Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio